Singh et al. (20) have identified stem-like cells lacking the expression of neural differentiation markers in pediatric brain tumors that express CD133, and showed that CD133+ human GBM cells can initiate tumor formation in the brains of immunodeficient mice (21). The gene discussed is PROM1; the disease is glioblastoma.